BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30523073)

  • 1. Utility of the Seattle Heart Failure Model for palliative care referral in advanced ambulatory heart failure.
    Ng Fat Hing N; MacIver J; Chan D; Liu H; Lu YTL; Malik A; Wang VN; Levy WC; Ross HJ; Alba AC
    BMJ Support Palliat Care; 2018 Dec; ():. PubMed ID: 30523073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting 1-Year Mortality in Outpatients With Heart Failure With Reduced Left Ventricular Ejection Fraction: Do Empiric Models Outperform Physician Intuitive Estimates? A Multicenter Cohort Study.
    Alba AC; Buchan TA; Saha S; Fan S; Demers C; Poon S; Mak S; Al-Hesayen A; Toma M; Zieroth S; Anderson K; Porepa L; Chih S; Giannetti N; Rac V; Levy WC; Ross HJ; Guyatt GH
    Circ Heart Fail; 2023 Jul; 16(7):e010312. PubMed ID: 37337896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of the Seattle Heart Failure Model in patients with advanced heart failure.
    Kalogeropoulos AP; Georgiopoulou VV; Giamouzis G; Smith AL; Agha SA; Waheed S; Laskar S; Puskas J; Dunbar S; Vega D; Levy WC; Butler J
    J Am Coll Cardiol; 2009 Jan; 53(4):334-42. PubMed ID: 19161882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing Palliative Care for Patients With Advanced Heart Failure Through Simple Prognostication Tools: A Comparison of the Surprise Question, the Number of Previous Heart Failure Hospitalizations, and the Seattle Heart Failure Model for Predicting 1-Year Survival.
    Blum M; Gelfman LP; McKendrick K; Pinney SP; Goldstein NE
    Front Cardiovasc Med; 2022; 9():836237. PubMed ID: 35479267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for heart transplantation.
    Sartipy U; Goda A; Yuzefpolskaya M; Mancini DM; Lund LH
    Am Heart J; 2014 Sep; 168(3):325-31. PubMed ID: 25173544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee.
    Gorodeski EZ; Chu EC; Chow CH; Levy WC; Hsich E; Starling RC
    Circ Heart Fail; 2010 Nov; 3(6):706-14. PubMed ID: 20798278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).
    Lanfear DE; Levy WC; Stehlik J; Estep JD; Rogers JG; Shah KB; Boyle AJ; Chuang J; Farrar DJ; Starling RC
    Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28465311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From statistical significance to clinical relevance: A simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failure.
    AbouEzzeddine OF; French B; Mirzoyev SA; Jaffe AS; Levy WC; Fang JC; Sweitzer NK; Cappola TP; Redfield MM
    J Heart Lung Transplant; 2016 Jun; 35(6):714-21. PubMed ID: 27021278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the Seattle Heart Failure Model in patients on cardiac resynchronization therapy.
    Perrotta L; Ricciardi G; Pieragnoli P; Chiostri M; Pontecorboli G; De Santo T; Bellocci F; Vitulano N; Emdin M; Mascioli G; Ricceri I; Porciani MC; Michelucci A; Padeletti L
    Pacing Clin Electrophysiol; 2012 Jan; 35(1):88-94. PubMed ID: 22054166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and Recalibration of Seattle Heart Failure Model in Japanese Acute Heart Failure Patients.
    Shiraishi Y; Kohsaka S; Nagai T; Goda A; Mizuno A; Nagatomo Y; Sujino Y; Fukuoka R; Sawano M; Kohno T; Fukuda K; Anzai T; Shadman R; Dardas T; Levy WC; Yoshikawa T
    J Card Fail; 2019 Jul; 25(7):561-567. PubMed ID: 30099192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced heart failure patients supported with ambulatory inotropic therapy: What defines success of therapy?
    Grubb CS; Truby LK; Topkara VK; Bohnen MS; Yuzefpolskaya M; DeFilippis EM; Kleet A; Nakagawa S; Haythe JH; Axsom K; Colombo P; Takeda K; Uriel N; Sayer G; Garan H; Naka Y; Farr M
    Am Heart J; 2021 Sep; 239():11-18. PubMed ID: 33984317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of observed survival after ventricular assist device placement versus predicted survival without assist device using the Seattle heart failure model.
    Pamboukian SV; Tallaj JA; Brown RN; Nielsen T; George JF; Kirklin JK; Holman WL; Levy WC
    ASAIO J; 2012; 58(2):93-7. PubMed ID: 22370679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triage of patients with moderate to severe heart failure: who should be referred to a heart failure center?
    Thorvaldsen T; Benson L; Ståhlberg M; Dahlström U; Edner M; Lund LH
    J Am Coll Cardiol; 2014 Feb; 63(7):661-671. PubMed ID: 24161453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Prognostic Heart Failure Models in Patients With Nonischemic Cardiomyopathy Undergoing Ventricular Tachycardia Ablation.
    Muser D; Liang JJ; Castro SA; Lanera C; Enriquez A; Kuo L; Magnani S; Birati EY; Lin D; Schaller R; Supple G; Zado E; Garcia FC; Nazarian S; Dixit S; Frankel DS; Callans DJ; Marchlinski FE; Santangeli P
    JACC Clin Electrophysiol; 2019 Jul; 5(7):801-813. PubMed ID: 31320008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Survival in Patients With Heart Failure With an Implantable Cardioverter Defibrillator: The Heart Failure Meta-Score.
    Alba AC; Walter SD; Guyatt GH; Levy WC; Fang J; Ross HJ; Lee DS
    J Card Fail; 2018 Nov; 24(11):735-745. PubMed ID: 29175281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of existing risk scores around heart transplantation: validation study in a 4-year cohort.
    Nguyen LS; Coutance G; Ouldamar S; Zahr N; Brechot N; Galeone A; Bougle A; Lebreton G; Leprince P; Varnous S
    Transpl Int; 2018 May; 31(5):520-530. PubMed ID: 29380444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle heart failure model (SHFM).
    Goda A; Williams P; Mancini D; Lund LH
    J Heart Lung Transplant; 2011 Nov; 30(11):1236-43. PubMed ID: 21764604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure.
    Dardas T; Li Y; Reed SD; O'Connor CM; Whellan DJ; Ellis SJ; Schulman KA; Kraus WE; Forman DE; Levy WC
    J Heart Lung Transplant; 2015 Aug; 34(8):1017-23. PubMed ID: 25940075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Prognostic Risk Scores in Elderly Chinese Patients with Heart Failure.
    Cheng Y; Chai K; Zhu W; Wan Y; Liang Y; Du M; Li Y; Sun N; Yang J; Wang H
    Clin Interv Aging; 2021; 16():1669-1677. PubMed ID: 34556979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.